Non-conventional signal transduction by type I interferons: The NF-κB pathway

Journal of Cellular Biochemistry

Volumn 102, Issue 5, 2007, Pages 1087-1094

  Du, Ziyun ^a   Wei, Lai ^a   Murti, Aruna ^a   Pfeffer, Susan R ^a   Fan, Meiyun ^a   Chuan, He Yang ^a   Pfeffer, Lawrence M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Gene expression; Interferon; JAK; NF B; Signal transduction; STAT

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON;

ANTIVIRAL ACTIVITY; CELL DEATH; CELL SURVIVAL; DNA BINDING; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; STATISTICAL SIGNIFICANCE;

ANIMALS; FORECASTING; GENE EXPRESSION; HUMANS; INTERFERON TYPE I; JANUS KINASES; MODELS, BIOLOGICAL; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 36849082588     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21535     Document Type: Review

References (29)

1. Baeuerle PA. 1998. IkB-NFkB structures: At the interface of inflammation control. Cell 95:729-731.
2. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M. 2004. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23:4202-4210.
3. Chen LF, Greene WC. 2004. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392-401.
4. Deb A, Haque SJ, Mogensen T, Silverman RH, Williams BR. 2001. RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J Immunol 166:6170-6180.
5. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17:525-535.
6. Isaacs A, Lindenmann J. 1957. Virus interference. 1. The interferon. Proc Roy Soc B 147:258-273.
7. Karin M, Yamamoto Y, Wang QM. 2004. The IKK NF-kappa B system: A treasure trove for drug development. Nat Rev Drug Discov 3:17-26.
8. Li Q, Withoff S, Verma IM. 2005. Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol 26:318-325.
9. Lin A, Karin M. 2003. NF-kappaB in cancer: A marked target. Semin Cancer Biol 13:107-114.
10. Panwalkar A, Verstovsek S, Giles F. 2004. Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies. Cancer 100:1578-1589.
11. Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S. 1998. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 58:2489-2499.
12. Pfeffer LM, Kim JG, Pfeffer SR, Carrigan DJ, Baker DP, Wei L, Homayouni R. 2004. The role of NF-κB in the antiviral action of interferon and interferon-regulated gene expression. J Biol Chem 279:31304-31311.
13. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375-386.
14. Ploegh HL. 2000. Immune and other responses to viral infections. Nutr Rev 58:S25-S30; discussion S63-S73.
15. Pomerantz JL, Baltimore D. 2002. Two pathways to NF-kappaB. Mol Cell 10:693-695.
16. Quivy V, Van Lint C. 2004. Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem Pharmacol 68:1221-1229.
17. Rani MR, Hibbert L, Sizemore N, Stark GR, Ransohoff RM. 2002. Requirement of phosphoinositide 3-kinase and Akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) gene. J Biol Chem 277:38456-38461.
18. Rothe M, Sarma V, Dixit VM, Goeddel DV. 1995. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269:1424-1427.
19. Sen R, Baltimore D. 1986. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47:921-928.
20. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495-1499.
21. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315:1274-1278.
22. Uddin S, Platanias LC. 2004. Mechanisms of Type-I interferon signal transduction. J Biochem Mol Biol 37:635-641.
23. Vestal DJ. 2005. The guanylate-binding proteins (GBPs): Proinflammatory cytokine-induced members of the dynamin superfamily with unique GTPase activity. J Interferon Cytokine Res 25:435-443.
24. Wei L, Sandbulte MR, Thomas PG, Webby RJ, Homayouni R, Pfeffer LM. 2006. NFκB negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem 281:11678-11684.
25. Yang CH, Murti A, Basu L, Kim JG, Pfeffer LM. 2000. IFN α/β promotes cell survival by activating NF-κB. Proc Natl Acad Sci USA 97:13631-13636.
26. Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM. 2001. Interferon α/β promotes cell survival by activating NF-κB through phosphatidylinositol-3 kinase and Akt. J Biol Chem 276:13756-13761.
27. Yang CH, Murti A, Pfeffer LM. 2005a. IFN induces NIK/TRAF dependent NF-κB activation to promote cell survival. J Biol Chem 280:31530-31536.
28. Yang CH, Murti A, Valentine WJ, Du Z, Pfeffer LM. 2005b. Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway. J Biol Chem 280:25849-25853.
29. Yang CH, Wei L, Pfeffer SR, Du Z, Murti A, Valentine WJ, Zheng Y, Pfeffer LM. 2007. Identification of CXCL11 as a STAT3-dependent gene induced by IFN. J Immunol 178:986-992.